55500 Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices 

8401, 6101 Executive Blvd., Bethesda, MD 

20892–8401, 301–402–6226, 

gm145a@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, Treatment 

Research Subcommittee. 

Date: October 4–5, 2006. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Madison Hotel, 1177—15th 

Street, NW., Washington, DC 20005. 

Contact Person: Kesinee Nimit, MD, Health 

Scientist Administrator, Office of Extramural 

Affairs, National Institute on Drug Abuse, 

NIH, DHHS, Room 220, MSC 8401, 6101 

Executive Boulevard, Bethesda, MD 20892–

8401, (301) 435–1432. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, EMember Conflict Group A. 

Date: October 4, 2006. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Madison Hotel, 1177—15th 

Street, NW., Washington, DC 20005. 

Contact Person: Mark R. Green, PhD, 

Deputy Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1431; mgreen1@nida.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA/ 

L Conflicts. 

Date: October 4, 2006. 

Time: 2 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott at Metro Center, 775 12th 

Street, NW., Washington, DC 20005. 

Contact Person: Rita Liu, PhD, Associate 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 212, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, 

301.435.1388, rliu@nida.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, EMember Conflict Group B. 

Date: October 4, 2006. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Madison Hotel, 1177 15th 

Street, NW., Washington, DC 20005. 

Contact Person: Mark R. Green, PhD, 

Deputy Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1431, mgreen1@nida.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA–

F Conflicts. 

Date: October 5, 2006. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Housing Center Events, 

1201 15th Street, NW., Washington, DC 

20005. 

Contact Person: Gerald L. McLaughlin, 

PhD, Scientific Review Administrator, Office 

of Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Blvd., Bethesda, MD 

20892–8401, 301–402–6626, 

gm145a@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Centers 

Review Committee. 

Date: October 23, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Chevy Chase, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Rita Liu, PhD, Associate 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 212, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, 301–

435–1388, rliu@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Program 

Projects. 

Date: October 24, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Chevy Chase, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Rita Liu, PhD, Associate 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 212, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, 301–

435–1388, rliu@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, Training 

and Career Development Subcommittee. 

Date: November 14–16, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Eliane Lazar-Wesley, PhD, 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, 6101 Executive 

Boulevard, Room 220, MSC 8401, Bethesda, 

MD 20892–8401, 301–415–4530, 

el6r@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.279, Drug Abuse and 

Addiction Research Program, National 

Institutes of Health, HHS) 

Dated: September 14, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8089 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group, Function, Integration, and 

Rehabilitation Sciences Subcommittee. 

Date: October 9–10, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel & Executive 

Meeting Center, 8120 Wisconsin Ave, 

Bethesda, MD 20814. 

Contact Person: Anne Krey, Scientific 

Review Administrator, Division of Scientific 

Review, National Institute of Child Health 

and Human Development, NIH, 6100 

Executive Blvd., Room 5B01, Bethesda, MD 

20892, 301–435–6908, ak4o@nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group, Reproduction, Andrology, 

and Gynecology Subcommittee. 

Date: October 11–12, 2006. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Jon M. Ranhand, PhD, 

Scientist Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, NIH, 6100 

Executive Boulevard, Room 5B01, Bethesda, 

MD 20892, (301) 435–6884, 

ranhandj@mail.nih.gov. 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices 55501 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group, Obstetrics and Maternal-Fetal 

Biology Subcommittee. 

Date: October 16–17, 2006. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Atrium Court Hotel, 3 Research 

Court, Rockville, MD 20850. 

Contact Person: Gopal M. Bhatnagar, PhD, 

Scientific Review Administrator, National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6100 Bldg Rm. 5B01, Rockville, MD 20852, 

(301) 435–6889, bhatnagg@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group, Pediatrics Subcommittee. 

Date: October 18–19, 2006. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel & Executive 

Meeting Center, 8120 Wisconsin Avenue, 

Bethesda, MD. 

Contact Person: Rita Anand, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, NIH, 9000 

Rockville Pike, MSC 7510, 6100 Building, 

Room 5B01, Bethesda, MD 20892, (301) 496–

1487, anandr@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group, Biobehavioral and Behavioral 

Sciences Subcommittee. 

Date: October 19–20, 2006. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza, 10 Thomas 

Circle, NW., Washington, DC 20005. 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, NIH, 6100 

Executive Boulevard, Room 5B01, Bethesda, 

MD 20892, (301) 435–6911, 

hopmannm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: September 13, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8090 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director National 

Institutes of Health, Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Advisory Committee on Research on 

Women’s Health. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Advisory Committee 

on Research on Women’s Health. 

Date: October 23–24, 2006. 

Time October 23, 2006, 9 a.m. to 5 p.m. 

Agenda: Provide advice to the Office of 

Research on Women’s Health (ORWH) on 

appropriate research activities with respect to 

women’s health and related studies to be 

undertaken by the national research 

institutes; to provide recommendations 

regarding ORWH activities; to meet the 

mandates of the office; and for discussion of 

scientific issues. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Time: October 24, 2006, 9 a.m. to 12:30 

p.m. 

Agenda: Same as above. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Contact Person: Joyce Rudick, Director, 

Program & Management, Office of Research 

on Women’s Health, Office of the Director, 

National Institutes of Health, Building 1, 

Room 201, Bethesda, MD 20892, 301/401–

1770. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www4.od.nih.gov/orwh/, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Background, 93.232, 

Loan Repayment Program for Research 

Generally, 93.39, Academic Research 

Enhancement Award, 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8085 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review, Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

October 2, 2006, 2 p.m. to October 2, 

2006, 5 p.m. National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892 which was published in the 

Federal Register on September 7, 2006, 

71 FR 52809–52810. 

The meeting will be held October 19, 

2006. The meeting time and location 

remain the same. The meeting is closed 

to the public. 

Dated: September 14, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8091 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERIVCES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Neural Degenerative 

Disorders and Glial Biology Study 

Section, October 4, 2006, 8 a.m. to 

October 5, 2006, 4 p.m., Wyndham 

Washington, DC, 1400 M Street, NW., 

Washington, DC, 20005 which was 

published in the Federal Register on 

September 7, 2006, 71 FR 52809–52810. 

The meeting will be held at the Hyatt 

Regency Bethesda, One Bethesda Metro 

Center, 7400 Wisconsin Avenue, 

Bethesda, MD 20814. The meeting dates 

and time remain the same. The meeting 

is closed to the public. 

Dated: September 14, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8093 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


sroberts on PROD1PC70 with NOTICES